NCT01916291View on ClinicalTrials.gov

Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38

PHASE2CompletedINTERVENTIONAL

Enrollment

189

Participants

Timeline

Start Date

August 25, 2013

Primary Completion Date

August 14, 2018

Study Completion Date

April 4, 2019

Conditions

Induction of Labor

Interventions

DRUG

Propess insertion group

Trial Locations (2)

110744

Seoul National University Hospital, Seoul

156707

Seoul Metropolitan Goverment Seoul National University Boramae Medical Center, Seoul

All Listed Sponsors

lead

Seoul National University Hospital

OTHER

NCT01916291 - Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38 | Biotech Hunter | Biotech Hunter